Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Ubash3a (ubiquitin associated and SH3 domain containing, A) Rattus norvegicus
Analyze
Symbol: Ubash3a
Name: ubiquitin associated and SH3 domain containing, A
CRRD ID: 1310305
Description: Predicted to be involved in negative regulation of T cell receptor signaling pathway and regulation of cytokine production. Predicted to localize to Golgi apparatus and nucleoplasm. Orthologous to human UBASH3A (ubiquitin associated and SH3 domain containing A); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; amphetamine; cadmium dichloride.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: LOC309666; ubiquitin-associated and SH3 domain-containing protein A
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0209,941,102 - 9,986,012 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl209,948,908 - 9,985,133 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.02012,121,174 - 12,164,639 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4209,583,659 - 9,620,767 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.1209,565,754 - 9,620,437 (+)NCBI
Celera2010,813,252 - 10,850,304 (+)NCBICelera
Cytogenetic Map20p12NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Expression

RNA-SEQ Expression

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 6.0)

Additional Information

External Database Links
Nomenclature History
 
More on Ubash3a
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1310305
Created: 2005-01-12
Species: Rattus norvegicus
Last Modified: 2020-08-20
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.